Search results for: 'm9de based engineering market'
- Related search terms
- marketing strategy hotel industry year 1999
- Market size energy technology
- marketing strategy homes industry year 16.9
- marketing strateg homes industry year 1.09
- market analyst of rf energy harvesting technolog
-
18 Apr 2022  |  North America  |  Market Research
Global Vaccine Growth Opportunities
Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally
Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Oct 2024  |  Global  |  Market Research
Image-guided Therapy Market, Global, 2024-2029
Increased Demand for Minimally Invasive Procedures and the Surge in Day Surgeries at Outpatient Facilities are Driving Transformational Growth
The image-guided therapy (IGT) market is growing rapidly, mainly driven by the rising preference for minimally invasive procedures, technological advancements in multimodal imaging, artificial intelligence, the use of software solutions that enable better clinical outcomes, and the high demand for precision medicine in oncology treatment. In additi...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Aug 2020  |  Global  |  Technology Research
Pipeline Analysis of Phase III Medical Diagnostic Devices: The Potential Game Changers and Growth Enablers
Lightweight, Portable, Sensor and Artificial Intelligence-based Medical Devices Re-defining Diagnostic Scenario in Healthcare
This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These pr...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jan 2022  |  North America  |  Market Research
Global CT Equipment Procedure Volumes and Reimbursement Growth Opportunities
Demand for Pulmonary and Abdomen-based Imaging Accelerating the Growth of CT Procedures
An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restrain...
$2,450.00
Special Price $1,837.50 save 25 %
-
30 Aug 2024  |  Global  |  Market Research
Population Health Management Sector, Global, 2024 2029
Operational and Financial Challenges are Driving Transformational Growth with the Shift toward Value-based Care
Healthcare providers worldwide struggle with operational, financial, and clinical challenges on top of workforce scarcity. Payers are challenged with rising healthcare costs and shrinking margins. Payers, providers, and policymakers seek ways to curb these expenditures. Population health management (PHM) software that enables cost containment strat...
$4,950.00
Special Price $4,207.50 save 15 %
-
31 May 2013  |  Europe  |  Market Research
Global Point-of-Care Testing (POCT) Market
Increasing Adoption of POCT in Emerging Countries will Provide Impetus to Market Growth
Reduced turnaround time and potential benefits of immediate diagnosis have resulted in an increased adoption of POCT in hospitals and physician office laboratories. However, whether POC tests replace traditional laboratory tests is a question still being debated in the scientific community. This study provides the market overview, market engineerin...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Mar 2022  |  North America  |  Market Research
Global eClinical Solutions Growth Opportunities
Decentralized Clinical Trials, Rising Mobile Health Adoption, and Cloud-based Platforms Lower Costs and Enhance Efficiency
The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Jan 2011  |  Asia Pacific  |  Market Research
Healthcare Information Technology Market in Australia
Healthcare Information Technology in Australian Market
This Market Engineering research service has been developed to address the dynamics of healthcare information technology in Australia. The market is divided into two sub segments including administrative and clinical healthcare IT. This research service presents the key findings of Australian healthcare information technology market. It provides i...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Dec 2025  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities, Forecast 2030
Fueled by Specialty Testing Expansion, Digital Workflow Innovation, and Value-Based Healthcare Demands
The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...
$4,950.00 -
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %